IDYA · IDEAYA Biosciences, Inc.
$36.30
-0.38 (-1.04%)
At close · Aug 14
Market Cap
$3.50B
Shares
96.49M
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Revenue
$218.71M
+3024.4%
FY2025
Net Income
-$113.7M
+58.6%
FY2025
Operating Margin
-72.84%
+4598.2pp
FY2025
Diluted EPS
-$1.28
+61.9%
FY2025
Operating Cash Flow
-$71.1M
+71.3%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| — | $218.71M | $7M | $23.39M | $50.93M | $27.94M | $19.54M | $0 | — | — | |
| $374.01M | $314.7M | $294.67M | $129.51M | $89.54M | $58.16M | $39.7M | $34.32M | $31.75M | $12.38M | |
| $77.07M | $63.32M | $39.3M | $28.31M | $23.9M | $20.05M | $15.18M | $9.95M | $4.67M | $2.05M | |
| $2.79M | $2.7M | $2.39M | $2.48M | $2.1M | $1.73M | $1.38M | $1.25M | $886K | $391K | |
| $451.08M | $378.02M | $333.98M | $157.81M | $113.43M | $78.21M | $54.88M | $44.27M | $36.42M | $14.44M | |
| -$216.95M | -$159.31M | -$326.98M | -$134.43M | -$62.5M | -$50.27M | -$35.34M | -$44.27M | -$36.42M | -$14.44M | |
| — | -72.84% | -4671.07% | -574.85% | -122.72% | -179.91% | -180.9% | — | — | — | |
| -$214.17M | -$156.61M | -$324.59M | -$131.95M | -$60.4M | -$48.54M | -$33.96M | -$43.03M | -$35.53M | -$14.05M | |
| — | — | — | — | — | — | — | $2.29M | $1.99M | $150K | |
| $41.93M | $45.62M | $52.5M | $21.47M | $3.85M | $506K | $849K | $2.3M | $2.07M | $2.43M | |
| — | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | — | |
| -$175.02M | -$113.7M | -$274.48M | -$112.96M | -$58.66M | -$49.76M | -$34.5M | -$41.98M | -$34.35M | -$11.86M | |
| — | -51.99% | -3921.1% | -483.05% | -115.17% | -178.1% | -176.55% | — | — | — | |
| -$178.21M | -$112.24M | -$274.23M | -$109.53M | -$60.81M | -$50.48M | -$34.55M | -$41.88M | -$34.38M | -$11.86M | |
| USD/shares | — | -$1.28 | -$3.36 | -$1.96 | -$1.42 | -$1.41 | -$1.40 | — | — | — |
| USD/shares | — | -$1.28 | -$3.36 | -$1.96 | -$1.42 | -$1.41 | -$1.40 | — | — | — |
| shares | — | 88.49M | 81.68M | 57.52M | 41.44M | 35.25M | 24.72M | 12.5M | 956.25K | 695.37K |
| shares | — | 88.49M | 81.68M | 57.52M | 41.44M | 35.25M | 24.72M | 12.5M | 956.25K | 695.37K |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.
Valuation
EV/Revenue
—
Peer median 7.46×
EV/EBIT
—
Peer median 27.68×
P/E (TTM)
—
Peer median 17.38×
Peer medians compare against the 224 similar-size Biotechnology companies (of 545 listed).
Key facts
CIK
1676725
CUSIP
45166A102
13F (30d)
271 filings
265 filers
Visit website
Investor relations